# Abbott Lowers 2026 Sales Growth Target

> Abbott cuts 2026 sales growth forecast to 6% as it plans Nutrition separation by end of 2027.
- Title: Abbott Lowers 2026 Sales Growth Target · TokenPost | Shortify
- Summary: Abbott cuts 2026 sales growth forecast to 6% as it plans Nutrition separation by end of 2027. Abbott lowered its 2026 comparable sales-growth outlook to 6%…
- Keywords: abbott, nutrition, seahawks, seattle, nfl, crypto, finance, Lowers, 2026, Sales, Growth, Target
- Source: TokenPost — https://tokenpost.com/news/business/37199
- Published: 2026-10-22T00:04:41+00:00
- Read time: 1 min
- Topics: abbott, nutrition, seahawks, seattle, nfl, crypto, finance
## Abbott's 2026 Sales Outlook
Abbott lowered its 2026 comparable sales-growth outlook to about 6% from the 6.5% to 7.5% range reaffirmed in July.
## Nutrition Separation Timeline
Abbott plans to distribute shares of an independent Nutrition company to shareholders by end of 2027.
## 2026 Guidance Details
Abbott narrowed 2026 adjusted diluted earnings guidance to $5.50 to $5.55 per share while Nutrition separation remains targeted for completion by end of 2027.
## Key takeaway

Abbott lowered its 2026 comparable sales-growth outlook to 6% from 6.5%-7.5% range, targeting Nutrition separation completion by end of 2027.